| Development Specimens |
| Name |
Biopsy 1 |
Biopsy 2 |
Prostatectomy |
| Patient 1 |
Atypical glands + small focus of cancer, GS6 (3+3); 03/2011 |
AC, GS6 (3+3);06/2012 |
Stage III (pT3a), GS7 (3+4); 12/2012 |
| Patient 2 |
Lots of AC, GS7 (4+3);11/2012 |
|
Stage II (pT2c), GS7 (3+4); 02/2013 |
| Patient 3 |
Benign; 08/2009 |
AC, GS7 (4+3); 09/2012 |
Stage III (pT3a), GS7 (3+4); 12/2012 |
| Patient 4 |
Lots of AC, GS6 (3+3);02/2012 |
|
Stage II (pT2c), GS7 (3+4); 03/2012 |
| Patient 5 |
Lots of AC, GS6 (3+3);11/2012 |
|
Stage III (pT3b), GS6 (3+3); 01/2013 |
| Validation Specimens |
| Patient 5 |
|
|
Benign tissue distal from tumor region; 01/2013 |
| Patient 6 |
Lots of AC, GS6 (3+3);5/2014 |
|
Stage II (pT2c), GS6 (3+3); 11/2014 |
| Patient 7 |
Lots of AC, GS6 (3+3);1/2013 |
|
Stage II (pT2c), GS6 (3+3); 5/2013 |
| Patient 8 |
Lots of AC, GS7 (3+4);2/2013 |
|
Stage II (pt2c), GS7 (3+4); 4/2013 |
| Patient Z |
|
|
Benign tissue distal from tumor region; extraction date N/A |
| HPrEpiC |
Isolated from normal human prostate tissue, cytokeratin 18 and 19 positive |
| LNCaP |
Isolated from human needle biopsy, androgen-sensitive prostate adenocarcinoma cells |
